World Orphan Drug Congress USA 2016
community download

Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders

Chris Cashman of Marinus Pharmaceuticals Inc.   joined us for World Orphan Drug Conference USA 2015 to present about ' Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders'
 
Download the presentation to learn about:
  • Ganaxalone: First-In-Class Therapeutic for Epilepsy and Neuropsychiatric Disorders
  • Diversified Clinical Stage Opportunities
  • Behaviors in Fragile X Syndrome
  • Intravenous Formulation

...and much more! 

 

Get your copy here! 

 
To find out more about Marinus Pharmaceuticals and Gaxalone , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC. 

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (862Kb in size)